Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (75)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Standeven, A. M.
Right arrow Articles by Kato, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Standeven, A. M.
Right arrow Articles by Kato, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Oxford University Press

research-article

Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium–DNA binding in vitro

Andrew M. Standeven, Karen E. Wetterhahn 1 and Ryuichi Kato 2

Department of Chemistry, Dartmouth College Hanover, NH 03755, USA
1Present address: Department of Experimental Pathology and Toxicology, Chemical Industry Institute of Toxicology Research Triangle Park, NC 27709, USA

2To whom correspondence should be addressed

Chromium(VI) reductase activity was measured in ultrafiltrates of rat lung after various pretreatments in vitro at 37°C and pH 7.0. Pretreatment of ultrafiltrates with L-ascorbate oxidase (EC 1.10.3.3 [EC] ), which specifically eliminated ascorbate, blocked {small tilde} 95% of chromium(VI) reductase activity in ultrafiltrates. Preincubation of ultrafiltrates with heat-denatured ascorbate oxidase or the sulfhydryl-blocking agent N-ethylmaleimide (NEM) had no significant effect on Cr(VI) reductase activity. In rat lung cytosols, L-ascorbate oxidase blocked {small tilde} 95% and NEM blocked {small tilde} 15% of Cr(VI) reductase activity. The extent of inhibition of Cr(VI) reductase activity in cytosols by L-ascorbate oxidase was significantly decreased to {small tilde}75% after addition of 1.0 mM NADPH. When Cr(VI) was incubated with salmon sperm nuclei suspended in rat lung cytosol for 15 min, Cr became bound to nuclear DNA. This Cr-DNA binding was completely inhibited by preincubation of rat lung cytosols with L-ascorbate oxidase and inhibited {small tilde} 60% by preincubation with NEM. Taken together these data suggest that ascorbate and/or ascorbate-dependent factors are the principal reductants of Cr(VT) in both ultrafiltrates and cytosols prepared from rat lung and ascorbate-dependent metabolism of Cr(VI) results in Cr binding to nuclear DNA in vitro. Although sulfhydryl-containing factors and NADPH-dependent factors only make a minor contribution to Cr(VI) reduction in rat lung cytosols, sulfhydryls may be significantly involved in the binding of Cr to nuclear DNA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Reynolds and A. Zhitkovich
Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53
Carcinogenesis, July 1, 2007; 28(7): 1613 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Reynolds, L. Stoddard, I. Bespalov, and A. Zhitkovich
Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair
Nucleic Acids Res., January 28, 2007; 35(2): 465 - 476.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Quievryn, J. Messer, and A. Zhitkovich
Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate
Carcinogenesis, November 1, 2006; 27(11): 2316 - 2321.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
P. Hu, E. L. Brodie, Y. Suzuki, H. H. McAdams, and G. L. Andersen
Whole-Genome Transcriptional Analysis of Heavy Metal Stresses in Caulobacter crescentus
J. Bacteriol., December 15, 2005; 187(24): 8437 - 8449.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
A D Dayan and A J Paine
Mechanisms of chromium toxicity, carcinogenicity and allergenicity: Review of the literature from 1985 to 2000
Human and Experimental Toxicology, September 1, 2001; 20(9): 439 - 451.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S.-M. Chuang, G.-Y. Liou, and J.-L. Yang
Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity
Carcinogenesis, August 1, 2000; 21(8): 1491 - 1500.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. L. Carlisle, D. E. Pritchard, J. Singh, B. M. Owens, L. J. Blankenship, J. M. Orenstein, and S. R. Patierno
Apoptosis and P53 Induction in Human Lung Fibroblasts Exposed to Chromium (VI): Effect of Ascorbate and Tocopherol
Toxicol. Sci., May 1, 2000; 55(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-M. P. Yuann, K. J. Liu, J. W. Hamilton, and K. E. Wetterhahn
In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium–DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of Osteogenic Disorder Shionogi rats following treatment with chromium(VI)
Carcinogenesis, July 1, 1999; 20(7): 1267 - 1275.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.